INS and Hypoglycemia: Again, when analysed separately, mortality risk was higher in individuals on insulin (alone or in combination) than in those on insulin secretagogues in each HbA1c target category and was not increased in patients treated with agents not causing hypoglycaemia and falling in the below-target category, as compared with those on lifestyle measures only.